{"id":7445,"date":"2021-12-16T08:00:29","date_gmt":"2021-12-16T13:00:29","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/lanreotide-acetate-cas-127984-74-1-rawat-untuk-akromegali-dan-tumor-neuroendokrin-bergejala\/"},"modified":"2021-12-16T08:00:29","modified_gmt":"2021-12-16T13:00:29","slug":"lanreotide-acetate-cas-127984-74-1-rawat-untuk-akromegali-dan-tumor-neuroendokrin-bergejala","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/ms\/product\/lanreotide-acetate-cas-127984-74-1-rawat-untuk-akromegali-dan-tumor-neuroendokrin-bergejala\/","title":{"rendered":"Lanreotide acetate CAS 127984-74-1 Rawat Untuk Akromegali dan tumor neuroendokrin bergejala"},"content":{"rendered":"<h2><strong>Lanreotide acetate CAS 127984-74-1 Rawat Untuk Akromegali dan tumor neuroendokrin bergejala<\/strong><\/h2>\n<p>Nama Produk: Lanreotide Acetate<br \/>\nSinonim: 10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2 -hidroksi-propil)-16-[(4-hidroksifenil)metil]-13-(1H-indol -3-ilmetil)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1 ,2-dithia-5,8,11,14, 17-pentazacycloicosane-4-carboxamide;Somatulina;LANREOTIDE ACETATE;3-(2-Naftalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl- L-lysyl-L-valyl-L-cysteinyl-L-threoninamide kitaran (2\u21927)-disulfide acetate;Angiopeptin acetate;10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan -2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)metil]-13-(1H-indol-3-ylmethyl)-6, 9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;Lanreotide Acetate USP\/EP\/BP<br \/>\n CAS: 127984-74-1<br \/>\nMF: C54H69N11O10S2<br \/>\nMW: 0<br \/>\nEINECS:<br \/>\nKategori Produk: Asid Amino &amp; Derivatif, Farmaseutikal, Perantaraan &amp; Derivatif<br \/>\nFail Mol: 127984-127984 1.mol<\/p>\n<p>Lanreotide acetate, somatostatin oktapeptida analog, mencapai pasaran dunia pertamanya di Perancis untuk akromegali apabila pembedahan atau radioterapi gagal memulihkan rembesan hormon pertumbuhan normal. Lanreotide adalah perencat selektif hormon pertumbuhan dan mengurangkan rembesan hormon pertumbuhan, thyrotropin, motilin dan polipeptida pankreas pada manusia. Lanreotide mempunyai sifat antiproliferatif dan dilaporkan dalam ujian klinikal untuk pencegahan restenosis berikutan angioplasti arteri koronari, untuk retinopati diabetik, dan sebagai terapi untuk psoriasis. Potensinya untuk tumor neuroendokrin dan kanser prostat responsif hormon juga telah ditunjukkan.<\/p>\n<p> <strong>Lanreotide Acetate CAS 127984-74-1 Sifat Kimia<\/strong><br \/>\nsuhu simpanan. -20\u00b0C<br \/>\nmembentuk serbuk<br \/>\nwarna putih ke putih pudar<\/p>\n<p> <strong>Fungsi dan Penggunaan Lanreotide Acetate CAS 127984-74-1<\/strong><br \/>\nLanreotide acetate, seperti perencat pertumbuhan semula jadi, lanreotide ialah perencat peptida banyak fungsi endokrin, neuroendokrin, eksokrin dan paracrine. Lanreotide lebih aktif dan mempunyai tempoh tindakan yang lebih lama daripada perencat pertumbuhan semula jadi. Kesan perencatannya terhadap rembesan hormon pertumbuhan adalah lebih selektif berbanding rembesan insulin, dan pada tahun 2017 FDA meluluskan lanreotide acetate untuk suntikan untuk rawatan tumor neuroendokrin.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nama Produk: Lanreotide Acetate<br \/>\nCAS: 127984-74-1<br \/>\nMF: C54H69N11O10S2<br \/>\nFail Mol: 127984-74-1.mol<\/p>\n","protected":false},"featured_media":4547,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[383],"product_tag":[2297],"class_list":{"0":"post-7445","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptida-anti-tumor","7":"product_tag-lanreotide-acetate-cas-127984-74-1-treat-for-acromegaly-and-symptomatic-neuroendocrine-tumors-ms","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product\/7445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/comments?post=7445"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/media\/4547"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/media?parent=7445"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product_brand?post=7445"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product_cat?post=7445"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product_tag?post=7445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}